Inactive Instrument

Semler Scientific, Inc. Stock Other OTC

Equities

SMLR

US81684M1045

Medical Equipment, Supplies & Distribution

Sales 2024 * 75.5M Sales 2025 * - Capitalization 179M
Net income 2024 * 26M Net income 2025 * - EV / Sales 2024 * 2.37 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * -
P/E ratio 2024 *
7.49 x
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 75.47%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 70 12-08-31
Director of Finance/CFO 52 22-04-30
Chief Operating Officer - 10-09-30
Members of the board TitleAgeSince
Chairman 59 23-04-18
Director/Board Member 68 20-08-12
Chief Executive Officer 70 12-08-31
More insiders
Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient’s vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.
Related indices
More about the company